Cooper Companies | COO - Current Assets



Cooper Companies reported $2.14B in Current Assets for its fiscal quarter ending in July of 2025.


Current Assets Change Date
Abbott USD 24.47B 1.32B Jun/2025
Align Technology USD 2.45B 46.03M Jun/2025
AtriCure USD 271.26M 19.77M Jun/2025
Avanos Medical USD 356M 3.6M Jun/2025
Bausch Health Companies USD 6.51B 782M Jun/2025
Baxter International USD 7.04B 1.82B Mar/2025
Bayer EUR 33.75B 1.08B Jun/2025
Becton, Dickinson and Co. USD 9B 331M Jun/2025
Boston Scientific USD 7.34B 415M Mar/2025
Cooper Companies USD 2.14B 12.1M Jul/2025
Dentsply International USD 1.97B 12M Jun/2025
Dexcom USD 5.03B 476.4M Jun/2025
Edwards Lifesciences USD 6.21B 72.7M Mar/2025
Globus Medical USD 1.73B 19.79M Jun/2025
Haemonetics USD 913.16M 21.82M Jun/2025
Hologic USD 3.42B 212.7M Jun/2025
Insulet USD 2.28B 48.7M Jun/2025
Integra LifeSciences USD 1.14B 35.58M Jun/2025
Intuitive Surgical USD 12.47B 592.4M Jun/2025
J&J USD 71.55B 15.66B Mar/2025
Medtronic USD 23.81B 1.3B Apr/2025
Merit Medical Systems USD 923.07M 35.56M Jun/2025
Novartis USD 25.94B 3.76B Jun/2025
ResMed USD 3.51B 297.18M Jun/2025
STAAR Surgical USD 292.79M 33.71M Jun/2025
Steris USD 2.06B 57.04M Jun/2025
Stryker USD 13B 19M Jun/2025
Tandem Diabetes Care USD 614.82M 48.62M Jun/2025
Teleflex USD 1.72B 184.95M Jun/2025
Zimmer Biomet Holdings USD 5.05B 536.3M Jun/2025